Skip to main content
Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
9.78
-0.17 (-1.71%)
At close: Jan 17, 2025, 4:00 PM
9.92
+0.14 (1.43%)
After-hours: Jan 17, 2025, 4:00 PM EST

Champions Oncology Revenue

Champions Oncology had revenue of $13.49M in the quarter ending October 31, 2024, with 16.56% growth. This brings the company's revenue in the last twelve months to $53.57M, up 7.19% year-over-year. In the fiscal year ending April 30, 2024, Champions Oncology had annual revenue of $50.16M, down -6.90%.

Revenue (ttm)
$53.57M
Revenue Growth
+7.19%
P/S Ratio
2.48
Revenue / Employee
$255,100
Employees
210
Market Cap
133.98M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 202450.16M-3.72M-6.90%
Apr 30, 202353.87M4.76M9.69%
Apr 30, 202249.11M8.07M19.66%
Apr 30, 202141.04M8.92M27.76%
Apr 30, 202032.12M5.06M18.68%
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro
Apr 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 87.70B
Merck & Co. 63.17B
AbbVie 55.53B
AstraZeneca 51.21B
Novartis AG 49.94B
Thermo Fisher Scientific 42.37B
Abbott Laboratories 41.22B
Revenue Rankings

CSBR News

More News